NeoGenomics

-$0.95 (-2.08%) Today

$0.00 (0.00%) As of 11:05 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments.

CEO

Mark Mallon

Employees

1,700

Headquarters

Fort Myers, Florida

Founded

1998

NEO Key Statistics

Market Cap

5.48B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

741.18K

High Today

$45.76

Low Today

$44.61

Open Price

$45.58

Volume

638.14K

52 Week High

$61.57

52 Week Low

$34.18

Analyst Ratings

92%

of 13 ratings

Buy

92.3%

Hold

7.7%

Sell

NEO Earnings

-$0.10

-$0.02

$0.06

$0.14

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 6, Pre-Market